PPARb/d brings IL-1 to Heal

01-Apr-2009


The skin is the most important barrier of the body providing protection against microbial infection, chemical or UV damage, dehydration and mechanical injuries. Repair of this organ after injury is thus a life saving priority. But how do skin cells know when to proliferate and at what rate? In the March 23, 2009 issue of the Journal of Cell Biology, Asst/P Tan Nguan Soon and colleagues reveal that skin fibroblasts use a protein called PPARβ/δ to make sure overlying epithelial cells don't proliferate too quickly. "Proliferation is important in early stages of wound healing," explains Tan. "But excessive proliferation isn't good: you can end up with hypertrophic scarring." Their results highlight how communications between different cell types are critical to maintain the skin as a barrier against the outside world.

Skin is made up of two main layers: the epidermis is the outer layer containing epithelial keratinocytes and the underlying dermis, made up of fibroblasts and other cells. Signals are exchanged between these layers to coordinate their function, but dissecting these signals is tricky. For example, PPARβ/δ is an important protein for maintaining healthy skin, but its precise function remains controversial. PPARβ/δ is a nuclear hormone receptor that plays important roles in diabetes, obesity and metabolic-associated illness.

“Fibroblasts often play important roles by communicating with epithelial cells. The exploration of the role of PPARb/d in the fibroblast biology in mice is hampered because currently it not possible to delete a gene exclusively from the dermis. We used organotypic skin culture to dissect these networks and to study how the different types of cells could communicate with each other,” says Tan.

Chong et al. discovered that PPARβ/δ in the fibroblasts has a homeostatic control of keratinocyte proliferation and differentiation by regulating IL-1 signaling. The authors found that PPARβ/δ stimulates the production of sIL-1ra, a protein that inhibits IL-1 signaling by competing for the IL-1 receptor. Normally, this would decrease the IL-1 signal received by fibroblasts and therefore reduce the growth factor signals sent back to the keratinocytes. But in PPARβ/δ's absence, fibroblasts keep stimulating keratinocyte division.

Pre-clinical studies are needed to realize the potential clinical applications of this work in wound healing. Currently, PPARb/d drugs for the treatment of various metabolic illnesses such as diabetes, are in trials are conducted by various pharmaceutical companies.

 

Nguan Soon Tan (center) and colleagues, including lead authors Ming Jie Tan (left) and Han Chung Chong (right) dissect the signals exchanged between fibroblasts and keratinocytes in mammalian skin. (from "In Focus")

 

 

 

Organotypic cultures reveal how the transcription factor PPARβ/ modulates the fibroblasts’ response to keratinocyte-released IL-1. Fibroblasts lacking either PPARβ/ or its transcriptional target, sIL-1ra (an inhibitor of IL-1 signaling; right panels), overproduce growth factors that induce the overlying keratinocytes to proliferate excessively (arrows). (from "In Focus").

 

The full article could be found here and the article is featured in the "In Focus" section of Journal of Cell Biology.

Principal Investigator
Asst Prof Tan Nguan Soon
NSTan@ntu.edu.sg

Team Members at SBS
Mr Chong Han Chung, Kelvin
Mr Tan Ming Jie
Ms Tan Siew Hwey
Mr Tan Chek Kun
Mr Ku Chee Wai
Mr Goh Yan Yih

Collaborators from Center for Integrative Genomics (Switzerland)
Prof Walter Wahli
Dr Liliane Michalik
Ms Virginie Philippe


Printer-friendly | Send to a friend